Suppr超能文献

葡萄牙宫颈癌筛查中的细胞学应用:2005/2006年全国健康调查结果

Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.

作者信息

Oliveira Mariana, Peleteiro Bárbara, Lunet Nuno

机构信息

1 Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal.

出版信息

Eur J Public Health. 2014 Apr;24(2):253-8. doi: 10.1093/eurpub/ckt077. Epub 2013 Jun 20.

Abstract

BACKGROUND

Understanding the patterns of cervical cytology use in preventive care may provide useful information for an efficient transition from opportunistic screening to organized programmes. We aimed to identify the determinants of non-use and underuse of cervical cytology in Portuguese women.

METHODS

As part of the fourth National Health Survey (2005/2006), 2191 women aged between 25 and 64 years were evaluated. The previous use of cervical cytology was classified as never or ever, and, among the latter, those having performed the latest cytology testing >5 years before were considered to underuse cervical cytology. We assessed the determinants of non-use and underuse through age- and education-adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs).

RESULTS

Overall, 23.5% of women had never used cervical cytology and 10.7% reported underuse. This prevalence increased with age and decreased with education and income. Compared with the national mean, the lowest risk of non-use and underuse was observed in Norte (non-use: OR = 0.31, 95% CI: 0.23-0.42; underuse: OR = 0.60, 95% CI: 0.40-0.91) and the highest in Alentejo (non-use: OR = 2.33, 95% CI: 1.78-3.06; underuse: OR = 2.37, 95% CI: 1.43-3.93). Women without a private health insurance (OR = 2.65, 95% CI: 1.29-5.47), who had no doctor appointments in the preceding 3 months (OR = 2.06, 95% CI: 1.22-3.48) and those who had never performed a mammography (OR = 17.78, 95% CI: 9.09-34.78) were more likely to have never performed a cervical cytology.

CONCLUSION

This study shows inequalities in the use of cervical cancer screening in Portugal and provides useful information for a better allocation of resources for cancer screening.

摘要

背景

了解预防性保健中宫颈细胞学检查的使用模式,可为从机会性筛查向有组织的筛查计划的有效过渡提供有用信息。我们旨在确定葡萄牙女性未进行和未充分进行宫颈细胞学检查的决定因素。

方法

作为第四次全国健康调查(2005/2006年)的一部分,对2191名年龄在25至64岁之间的女性进行了评估。先前宫颈细胞学检查的使用情况分为从未使用或曾经使用,在曾经使用者中,那些在5年多以前进行过最近一次细胞学检查的被视为未充分使用宫颈细胞学检查。我们通过年龄和教育程度调整后的优势比(OR)及相应的95%置信区间(95%CI)评估未使用和未充分使用的决定因素。

结果

总体而言,23.5%的女性从未使用过宫颈细胞学检查,10.7%的女性报告未充分使用。这种患病率随年龄增加而上升,随教育程度和收入降低。与全国平均水平相比,在北部地区未使用和未充分使用的风险最低(未使用:OR = 0.31,95%CI:0.23 - 0.42;未充分使用:OR = 0.60,95%CI:0.40 - 0.91),在阿连特茹地区最高(未使用:OR = 2.33,95%CI:1.78 - 3.06;未充分使用:OR = 2.37,95%CI:1.43 - 3.93)。没有私人医疗保险的女性(OR = 2.65,95%CI:1.29 - 5.47)、在过去3个月内没有预约看医生的女性(OR = 2.06,95%CI:1.22 - 3.48)以及从未进行过乳房X光检查的女性(OR = 17.78,95%CI:9.09 - 34.78)更有可能从未进行过宫颈细胞学检查。

结论

本研究显示了葡萄牙在宫颈癌筛查使用方面的不平等,并为更好地分配癌症筛查资源提供了有用信息。

相似文献

1
Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.
Eur J Public Health. 2014 Apr;24(2):253-8. doi: 10.1093/eurpub/ckt077. Epub 2013 Jun 20.
2
Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
Eur J Cancer Prev. 2009 Nov;18(6):482-8. doi: 10.1097/CEJ.0b013e328330eb47.
3
Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey.
Eur J Public Health. 2013 Jun;23(3):386-92. doi: 10.1093/eurpub/cks103. Epub 2012 Aug 8.
4
Cervical cytology use in Portugal: Results from the National Health Survey 2014.
J Obstet Gynaecol Res. 2019 Jul;45(7):1286-1295. doi: 10.1111/jog.13974. Epub 2019 Apr 29.
5
Inequalities in adherence to cervical cancer screening in Portugal.
Eur J Cancer Prev. 2021 Mar 1;30(2):171-177. doi: 10.1097/CEJ.0000000000000612.
6
Prevalence and determinants in cytology testing for cervical cancer screening in Spain (2006-14).
Eur J Public Health. 2018 Jun 1;28(3):410-415. doi: 10.1093/eurpub/cky015.
7
Mammography Use in Portugal: National Health Survey 2014.
Prev Chronic Dis. 2017 Oct 19;14:E100. doi: 10.5888/pcd14.170054.
8
Social disparities in access to breast and cervical cancer screening by women living in Spain.
Public Health. 2015 Jul;129(7):881-8. doi: 10.1016/j.puhe.2015.02.021. Epub 2015 Mar 25.
9
Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
Ann Epidemiol. 2019 Aug;36:40-47. doi: 10.1016/j.annepidem.2019.06.002. Epub 2019 Jun 21.
10
Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
Acta Med Port. 2023 Sep 1;36(9):577-587. doi: 10.20344/amp.19443. Epub 2023 Jun 19.

本文引用的文献

2
How to improve cervical cancer screening in Switzerland?
Swiss Med Wkly. 2012 Aug 13;142:w13663. doi: 10.4414/smw.2012.13663. eCollection 2012.
3
Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey.
Eur J Public Health. 2013 Jun;23(3):386-92. doi: 10.1093/eurpub/cks103. Epub 2012 Aug 8.
4
[Cervical cancer screening in Germany. Current status].
Pathologe. 2012 Jul;33(4):286-92. doi: 10.1007/s00292-012-1579-7.
7
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
8
Cervical cancer screening in Bulgaria--past and present experience.
Tumori. 2010 Jul-Aug;96(4):538-44. doi: 10.1177/030089161009600405.
9
Past, present and future of the cervical cancer screening in Latvia.
Tumori. 2010 Jul-Aug;96(4):529-37. doi: 10.1177/030089161009600404.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验